Protective effect of L-arginine in experimentally induced myocardial ischemia: Comparison with aspirin

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 16, Issue 1, 2011, Pages 53-62

  Saleh, Alaaeldin I ^a   Abdel Maksoud, Sahar M ^a   El Maraghy, Shohda A ^b   Gad, Mohamed Z ^a  

^a German University in Cairo   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

aspirin; hypercholesterolemia; isoproterenol; L arginine; myocardial ischemia

Indexed keywords

ACETYLSALICYLIC ACID; ARGININE; CHOLESTEROL; CREATINE KINASE MB; DRINKING WATER; FIBRINOGEN; ISOPRENALINE; LOW DENSITY LIPOPROTEIN; TROPONIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKNESS; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; FIBRINOGEN BLOOD LEVEL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HISTOPATHOLOGY; HYPERCHOLESTEROLEMIA; MALE; NONHUMAN; NUTRITIONAL STATUS; OXIDATION; PRIORITY JOURNAL; PROTHROMBIN TIME; RABBIT; THROMBOCYTE AGGREGATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AORTA; ARGININE; ASPIRIN; CARDIOTONIC AGENTS; CHOLESTEROL, DIETARY; CORONARY VESSELS; DIETARY SUPPLEMENTS; ISOPROTERENOL; LIPOPROTEINS, LDL; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; OXIDATION-REDUCTION; PLATELET AGGREGATION; RABBITS; SYMPATHOMIMETICS; TUNICA INTIMA;

EID: 79951501911     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248410378506     Document Type: Article

References (71)

1. Gasser R., Schafhalter I., Wolff P., Schwarz T., Fürschuss W., Klein W. Experimental models and definitions of myocardial ischemia: a review. Int J Angiol. 1994 ; 3: 154-156.
2. Grimm D., Elsner D., Schunkert H., et al. Development of heart failure following isoproterenol administration in the rat: role of renin-angiotensin system. Cardiovas Res. 1998 ; 37 (1). 91-100. (Pubitemid 28122620)
3. Shen, H. Illustrated Pharmacology Memory Cards: PharMnemonics. Minireview, 1st edition. United Kingdom ; 2009.
4. Wexler BC, Greenberg BP Protective effects of clofibrate on isoproterenol-induced myocardial infarction in arteriosclerotic and non-arteriosclerotic rats. Atherosclerosis. 1978 ; 29 (3). 373-395. (Pubitemid 8321593)
5. Roy S., Roy G., Mishra SC, Ravi Prakash V. Role of nitric oxide in central regulation of humoral immune response in rats. Indian J Pharmacol. 2000 ; 32 (5). 318-320.
6. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993 ; 329 (27). 2002-2012.
7. Boger RH, Bode-Boger SM The clinical pharmacology of L-arginine. Annu Rev Pharmacol Toxicol. 2001 ; 41: 79-99. (Pubitemid 32385883)
8. Wu G., Meininger CJ Arginine nutrition and cardiovascular function. J Nutr. 2000 ; 130 (11). 2626-2629.
9. Dass UN L-arginine, nitric oxide and collagen vascular diseases: a potential relationship. Nutrition. 1992 ; 8 (5). 371.
10. Böger RH, Bode-Böger SM, Mügge A., et al. Supplementation of hypercholesterolemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis. 1995 ; 117 (2). 273-284.
11. Jacobs M., Plane F., Bruckdorfer KR Native and oxidized low-density lipoproteins have different inhibitory effects on endothelium-derived relaxing factor in the rabbit aorta. Br J Pharmacol. 1990 ; 100 (1). 21-26. (Pubitemid 20161423)
12. Liao JK, Shin WS, Lee WY, Clark SL Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem. 1995 ; 270 (1). 319-324.
13. Weyrich AS, Ma XL, Lefer AM The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation. 1992 ; 86 (1). 279-288.
14. Govan CD The effect of salicylate administration on prothrombin time. J Pediatr. 1946 ; 29: 629-636.
15. Piper PJ, Vane JR The release of prostaglandins during anaphylaxis in guinea-pig isolated lungs. In: Mantegazza P, Horton EW, eds. Prostaglandins, Peptides, and Amines. London, UK: Academic Press ; 1969: 15-19.
16. Conti CR, Hill JA, Mayfield WR Unstable angina pectoris: pathogenesis and management. Curr Probl Cardiol. 1989 ; 14 (10). 549-624.
17. Gokkusu C., Oz H. Effect of thymosin fraction 5 (F5) on erythrocyte glutathione and lipid peroxide levels in hypercholesterolemic rabbits. Int Vitam Nutr Res. 1991 ; 61 (1). 87-90.
18. Cooke JP, Singer AH, Tsao P., Zera P., Rowan RA, Billingham ME Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest. 1992 ; 90 (3). 1168-1172.
19. Yi G., Qi-zhang W., Bing-shan T., et al. Effects of aspirin on atherosclerosis and the cyclooxygenase-2 expression in the atherosclerotic rabbits. Chin Med J. 2006 ; 119 (21). 1808-1814.
20. Kela AK, Reddy LP, Thombre DP ECG findings in normal rats after administration of Isoproterenol. Indian J Physiol Pharmacol. 1980 ; 24 (2). 84-90. (Pubitemid 10013550)
21. Sedgwick CJ Anesthesia for rabbits. Vet Clin North Am Food Anim Pract. 1986 ; 2 (3). 731-736. (Pubitemid 17189394)
22. Tietz NW Clinical Guide to Laboratory Tests. 3rd ed. Philadelphia, PA: WB Saunders Co ; 1995.
23. Würzburg U., Hennrich N., Orth HD, Lang H. Quantitative determination of creatine kinase isoenzyme catalytic concentrations in serum using immunological methods. J Clin Chem Clin Biochem. 1977 ; 15 (3). 131-137. (Pubitemid 8061823)
24. Etievent J., Chocron S., Toubin G., et al. The use of cardiac troponin I as a marker of peri-operative myocardial ischemia. Ann Thorac Surg. 1995 ; 59 (5). 1192-1194.
25. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol. 1957 ; 17 (4). 237-246.
26. Zhang A., Vertommen J., Van Gaal L., De Leeuw I. A rapid and simple method for measuring the susceptibility of low-density-lipoprotein and very-low-density-lipoprotein to copper-catalyzed oxidation. Clin Chim Acta. 1994 ; 227 (1-2). 159-173. (Pubitemid 24227308)
27. Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962 ; 194 (37). 927-929.
28. Banchroft JD, Stevens A., Turner DR Theory and Practice of Histological Techniques. 4th ed. New York, London, San Francisco, Tokyo: Churchill Livingstone ; 1996.
29. Golino P., Maroko PR, Carew TE The effect of acute hypercholesterolemia on myocardial infarct size and the NO reflow phenomena during coronary occlusion-reperfusion. Circulation. 1987 ; 75 (1). 292-298. (Pubitemid 17234570)
30. Sakamoto S., Kashiki M., Imai N., Liang CS, Hood WB Jr. Effects of short-term, diet-induced hypercholesterolemia on systemic hemodynamics, myocardial blood flow, and infarct size in awake dogs with acute myocardial infarction. Circulation. 1991 ; 84 (1). 378-386.
31. Hoshida S., Nishida M., Yamashita N., et al. Amelioration of severity of myocardial injury by a nitric oxide donor in rabbits fed a cholesterol-rich diet. J Am Coll Cardiol. 1996 ; 27 (4). 902-909.
32. Bloom S., Davis DL Calcium as mediator of isoproterenol induced myocardial necrosis. Am J Pathol. 1972 ; 69 (3). 459-470.
33. Tsao PS, McEvoy LM, Drexler H., Butcher EC, Cooke JP Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. Circulation. 1994 ; 89 (5). 2176-2182. (Pubitemid 24142796)
34. El-Maraghy SA, Gad MZ, Fahim AT, Hamdy MA L-Arginine supplement, the natural protection from cardiovascular disease: unraveling the biochemical mechanisms. Arab J Med. 2007 ; 33 (3). 333-353.
35. Nematbakhsh M., Haghjooyjavanmard S., Mahmoodi F., Monajemi AR The effect of L-arginine on serum lipids and nitrite levels, and the number of apoptotic cells, iNOS and eNOS expressions of aorta after the formation of fatty streaks in rabbit. J Appl Biomed. 2008 ; 6 (4). 203-210.
36. Acikel M., Buyukokuroglu ME, Erdogan F., Akosy H., Bozkurt E., Senocak H. Protective effect of dantrolene against myocardial injury induced by isoproterenol in rats: biochemical and histological findings. Int J Cardiol. 2005 ; 98 (3). 389-94. (Pubitemid 40247926)
37. Senthil S., Sridevi M., Pugalendi KV Cardioprotective effect of oleanolic acid on isoproterenol-induced myocardial ischemia in rats. Toxicol Pathol. 2007 ; 35 (3). 418-423.
38. Otsu N., Yamaguchi I., Komatsu E., Miyazawa K. Changes in creatine kinase M localization in acute ischemic myocardial cells. Circ Res. 1993 ; 73 (5). 935-942. (Pubitemid 23306138)
39. Napoli C., Postiglione A., Triggiani M., et al. Oxidative structural modifications of low density lipoprotein in homozygous familial hypercholesterolemia. Atherosclerosis. 1995 ; 118 (2). 259-273. (Pubitemid 26013164)
40. Ignarro LJ, Cirino G., Napoli C. Nitric oxide as a signaling molecule in the vascular system: an overview. J Cardiovasc Pharmacol. 1999 ; 34 (6). 876-884.
41. Chatelain P., Gremel M., Brotelle R. Prevention of amiodarone of phospholipid depletion in isoproterenol-induced ischemia in rats. Eur J Pharmacol. 1987 ; 144 (1). 83-90. (Pubitemid 18005057)
42. Sato T., Maegawa H., Kometani M., Fujii T. Collagen-induced calcium influx is enhanced in platelets from hypercholesterolemic rabbits. Thromb Res. 1985 ; 40 (1). 59-68. (Pubitemid 16204027)
43. Cook NS, Ubben D. Fibrinogen as major risk factor in cardiovascular disease. Trends Pharmacol Sci. 1990 ; 11 (11). 444-451. (Pubitemid 20351929)
44. Chan P., Tomlinsoin B., Tsai CW, Pan WH, Lee YS Thrombophilia in patients with hypercholesterolemia. Metabolism. 1996 ; 45 (8). 966-969. (Pubitemid 26282548)
45. Gurfinkel E., Bozovich G., Cerdá M., Mejaíl I., Oxilia A., Mautner B. Time significance of acute thrombotic reactant markers in patients with and without silent myocardial ischemia and overt unstable angina pectoris. Am J Cardiol. 1995 ; 76 (3). 121-124.
46. Kraml P., Syrovátka P., Stípek S., et al. Hyperlipoproteinemia impairs endothelium-dependent vasodilation. Physiol Res. 2004 ; 53 (5). 471-480. (Pubitemid 39486703)
47. Yi G., Qi-zhang W., Bing-shan T., et al. Effects of aspirin on atherosclerosis and the cyclooxygenase-2 expression in the atherosclerotic rabbits. Chin Med J. 2006 ; 119 (21). 1808-1814.
48. Yada T., Kaji S., Akasaka T., et al. Changes of asymmetric dimethylarginine, nitric oxide, tetrahydrobiopterin, and oxidative stress in patients with acute myocardial infarction by medical treatments. Clin Hemorheol Microcirc. 2007 ; 37 (3). 269-276. (Pubitemid 350032245)
49. Steer KA, Wallace TM, Bolton CH, Hartog M. Aspirin protects low density lipoprotein from oxidative modification. Heart. 1997 ; 77 (4). 333-337. (Pubitemid 27208173)
50. Husain S., Andrews NP, Mulcahy D., Panza JA, Quyyumi AA Aspirin improves endothelial dysfunction in atherosclerosis. Circulation. 1998 ; 97 (8). 716-720. (Pubitemid 28135332)
51. Roth GJ, Majerus PW The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein. J Clin Invest. 1975 ; 56 (3). 624-632.
52. Lopez-Farre A., Caramelo C., Esteban A., et al. Effects of aspirin on platelet-neutrophil interactions: role of nitric oxide and endothelin-1. Circulation. 1995 ; 91 (7). 2080-2088.
53. Bjornsson TD, Schneider DE, Berger H. Aspirin acetylates fibrinogen and enhances fibrinolysis. Fibrinolytic effect is independent of changes in plasminogen activator levels. J Pharmacol Exp Ther. 1989 ; 250 (1). 154-161. (Pubitemid 19194985)
54. Ajjan RA, Standeven KF, Khanbhai M., et al. Effects of aspirin on clot structure and fibrinolysis using a novel in vitro cellular system. Arterioscler Thromb Vasc Biol. 2009 ; 29 (5). 712-717.
55. Szczeklik A., Krzanowski M., Gora P., Radwan J. Antiplatelet drugs and generation of thrombin in clotting blood. Blood. 1992 ; 80 (8). 2006-2011.
56. Jacek M., Anetta U., Robert U., Jan B., Andrzej S. Treatment with simvastatin and low-dose aspirin depresses thrombin generation in patients with coronary heart disease and borderline-high cholesterol levels. Thromb Haemost. 2001 ; 85 (2). 221-225.
57. Guo Y., Jiang X., Chen S., Zhao HW, Gu KY Changes of C-reactive protein level and prognosis of ischemic stroke. Chin J Clin Rehabil. 2004 ; 8: 753-755. (Pubitemid 38637077)
58. Thrombosis Prevention Trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework. Lancet. 1998 ; 351 (9098). 233-241.
59. Wang BY, Singer AH, Tsao PS, Drexler H., Kosek J., Cooke JP Dietary arginine prevents atherogenesis in the coronary artery of hypercholesterolemic rabbits. J Am Coll Cardiol. 1994 ; 23 (2). 452-458. (Pubitemid 24049378)
60. Böger RH, Bode-Böger SM, Brandes RP. Dietary L-arginine reduces the progression of atherosclerosis in cholesterol-fed rabbits: comparison with lovastatin. Circulation. 1997 ; 96 (4). 1282-1290. (Pubitemid 27344234)
61. Carrier M., Pellerin M., Perrault LP, et al. Cardioplegic arrest with L-arginine improves myocardial protection: results of a prospective randomized clinical trial. Ann Thorac Surg. 2002 ; 73 (3). 837-842.
62. Kumar P., Agarwal JL, Kumar A. Effect of long term oral administration of L-arginine on experimentally produced myocardial ischemia in rabbits. Indian J Physiol Pharmacol. 2007 ; 51 (2). 147-152. (Pubitemid 47262278)
63. Jablecka A., Checiñski P., Krauss H., Micker M., Ast J. The influence of two different doses of L-arginine oral supplementation on nitric oxide (NO) concentration and total antioxidant status (TAS) in atherosclerotic patients. Med Sci Monit. 2004 ; 10 (1). CR29 - CR32.
64. Wascher TC, Posch K., Wallner C., Hermetter A., Kostner GM, Graier WF Vascular effects of L-arginine: anything beyond a substrate for the NO synthase ? Biochem Biophys Res Commun. 1997 ; 234 (1). 35-38. (Pubitemid 27267526)
65. Wolf A., Zalpour C., Theilmeier G., et al. Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans. J Am Coll Cardiol. 1997 ; 29 (3). 479-485. (Pubitemid 27116086)
66. Diodati JG, Dakak N., Gilligan DM, Quyyumi AA Effect of atherosclerosis on endothelium-dependent inhibition of platelet activation in humans. Circulation. 1998 ; 98 (1). 17-24. (Pubitemid 28312074)
67. Udvardy M., Posan E., Palatka K., Altorjay I., Harsfalvi J. Effect of L-arginine on in vitro plasmin generation and fibrinogenolysis. Thromb Res. 1997 ; 87 (1). 75-82. (Pubitemid 27333264)
68. Cylwik D., Mogielnicki A., Kramkowski K., Stokowski J., Buczko W. Antithrombotic effect of L-arginine in hypertensive rats. J phys Pharmacol. 2004 ; 55 (3). 563-574. (Pubitemid 39318848)
69. McNamara DB, Bedi B., Aurora H., et al. L-arginine inhibits balloon catheter-induced intimal hyperplasia. Biochem Biophys Res Commun. 1993 ; 193 (1). 291-296. (Pubitemid 23199945)
70. Drexler H., Zeiher AM, Meinzer K., Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet. 1991 ; 338 (8782-8783). 1546-1550.
71. Hayashi T., Juliet PAR, Matsui-Hirai H., et al. L-citrulline and L-arginine supplementation retards the progression of high-cholesterol-diet- induced atherosclerosis in rabbits. Proc Natl Acad Sci U S A. 2005 ; 102 (38). 3681-13686.